181 related articles for article (PubMed ID: 31308004)
1. A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers.
Keith RL; Blatchford PJ; Merrick DT; Bunn PA; Bagwell B; Dwyer-Nield LD; Jackson MK; Geraci MW; Miller YE
Cancer Prev Res (Phila); 2019 Oct; 12(10):721-730. PubMed ID: 31308004
[TBL] [Abstract][Full Text] [Related]
2. Oral iloprost improves endobronchial dysplasia in former smokers.
Keith RL; Blatchford PJ; Kittelson J; Minna JD; Kelly K; Massion PP; Franklin WA; Mao J; Wilson DO; Merrick DT; Hirsch FR; Kennedy TC; Bunn PA; Geraci MW; Miller YE
Cancer Prev Res (Phila); 2011 Jun; 4(6):793-802. PubMed ID: 21636546
[TBL] [Abstract][Full Text] [Related]
3. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia.
Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R
Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia.
Kennedy TC; Franklin WA; Prindiville SA; Cook R; Dempsey EC; Keith RL; Hirsch FR; Merrick TA; Shroyer KR; Petty TL; Byers T; Bunn PA; Miller YE
Lung Cancer; 2005 Aug; 49(2):187-91. PubMed ID: 16022912
[TBL] [Abstract][Full Text] [Related]
5. A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia.
Lam S; Mandrekar SJ; Gesthalter Y; Allen Ziegler KL; Seisler DK; Midthun DE; Mao JT; Aubry MC; McWilliams A; Sin DD; Shaipanich T; Liu G; Johnson E; Bild A; Lenburg ME; Ionescu DN; Mayo J; Yi JE; Tazelaar H; Harmsen WS; Smith J; Spira AE; Beane J; Limburg PJ; Szabo E;
Cancer Prev Res (Phila); 2016 Dec; 9(12):906-914. PubMed ID: 27658890
[TBL] [Abstract][Full Text] [Related]
6. Randomized phase II trial of sulindac for lung cancer chemoprevention.
Limburg PJ; Mandrekar SJ; Aubry MC; Ziegler KL; Zhang J; Yi JE; Henry M; Tazelaar HD; Lam S; McWilliams A; Midthun DE; Edell ES; Rickman OB; Mazzone P; Tockman M; Beamis JF; Lamb C; Simoff M; Loprinzi C; Szabo E; Jett J;
Lung Cancer; 2013 Mar; 79(3):254-61. PubMed ID: 23261228
[TBL] [Abstract][Full Text] [Related]
7. Endobronchial miRNAs as biomarkers in lung cancer chemoprevention.
Mascaux C; Feser WJ; Lewis MT; Barón AE; Coldren CD; Merrick DT; Kennedy TC; Eckelberger JI; Rozeboom LM; Franklin WA; Minna JD; Bunn PA; Miller YE; Keith RL; Hirsch FR
Cancer Prev Res (Phila); 2013 Feb; 6(2):100-8. PubMed ID: 23268837
[TBL] [Abstract][Full Text] [Related]
8. A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia.
Lam S; MacAulay C; Le Riche JC; Dyachkova Y; Coldman A; Guillaud M; Hawk E; Christen MO; Gazdar AF
J Natl Cancer Inst; 2002 Jul; 94(13):1001-9. PubMed ID: 12096085
[TBL] [Abstract][Full Text] [Related]
9. A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer.
Kelly K; Kittelson J; Franklin WA; Kennedy TC; Klein CE; Keith RL; Dempsey EC; Lewis M; Jackson MK; Hirsch FR; Bunn PA; Miller YE
Cancer Prev Res (Phila); 2009 May; 2(5):440-9. PubMed ID: 19401528
[TBL] [Abstract][Full Text] [Related]
10. Higher levels of the anti-inflammatory protein CC10 are associated with improvement in bronchial dysplasia and sputum cytometric assessment in individuals at high risk for lung cancer.
Chen J; Lam S; Pilon A; McWilliams A; Macaulay C; Szabo E
Clin Cancer Res; 2008 Mar; 14(5):1590-7. PubMed ID: 18316584
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer chemoprevention with celecoxib in former smokers.
Mao JT; Roth MD; Fishbein MC; Aberle DR; Zhang ZF; Rao JY; Tashkin DP; Goodglick L; Holmes EC; Cameron RB; Dubinett SM; Elashoff R; Szabo E; Elashoff D
Cancer Prev Res (Phila); 2011 Jul; 4(7):984-93. PubMed ID: 21733822
[TBL] [Abstract][Full Text] [Related]
12. Long-term impact of smoking on lung epithelial proliferation in current and former smokers.
Lee JJ; Liu D; Lee JS; Kurie JM; Khuri FR; Ibarguen H; Morice RC; Walsh G; Ro JY; Broxson A; Hong WK; Hittelman WN
J Natl Cancer Inst; 2001 Jul; 93(14):1081-8. PubMed ID: 11459869
[TBL] [Abstract][Full Text] [Related]
13. Biological activity of celecoxib in the bronchial epithelium of current and former smokers.
Kim ES; Hong WK; Lee JJ; Mao L; Morice RC; Liu DD; Jimenez CA; Eapen GA; Lotan R; Tang X; Newman RA; Wistuba II; Kurie JM
Cancer Prev Res (Phila); 2010 Feb; 3(2):148-59. PubMed ID: 20103722
[TBL] [Abstract][Full Text] [Related]
14. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
[TBL] [Abstract][Full Text] [Related]
15. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.
Lee JS; Lippman SM; Benner SE; Lee JJ; Ro JY; Lukeman JM; Morice RC; Peters EJ; Pang AC; Fritsche HA
J Clin Oncol; 1994 May; 12(5):937-45. PubMed ID: 8164045
[TBL] [Abstract][Full Text] [Related]
16. Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers.
Khuri FR; Lee JS; Lippman SM; Lee JJ; Kalapurakal S; Yu R; Ro JY; Morice RC; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):311-8. PubMed ID: 11319170
[TBL] [Abstract][Full Text] [Related]
17. Sex-related differences in bronchial epithelial changes associated with tobacco smoking.
Lam S; leRiche JC; Zheng Y; Coldman A; MacAulay C; Hawk E; Kelloff G; Gazdar AF
J Natl Cancer Inst; 1999 Apr; 91(8):691-6. PubMed ID: 10218506
[TBL] [Abstract][Full Text] [Related]
18. The finding of premalignant lesions is not associated with smoking cessation in chemoprevention study volunteers.
Schook RM; Postmus BB; van den Berg RM; Sutedja TG; Man de FS; Smit EF; Postmus PE
J Thorac Oncol; 2010 Aug; 5(8):1240-5. PubMed ID: 20581710
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer chemoprevention: an integrated approach.
Lippman SM; Spitz MR
J Clin Oncol; 2001 Sep; 19(18 Suppl):74S-82S. PubMed ID: 11560978
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women.
Ebbert JO; Yang P; Vachon CM; Vierkant RA; Cerhan JR; Folsom AR; Sellers TA
J Clin Oncol; 2003 Mar; 21(5):921-6. PubMed ID: 12610194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
